−£19k
vs Mar 2025Active04880477Private limited companyCambridge
GRANTA BIOTECHNOLOGY LIMITED
Significant control: Jason Peter Brown (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Granta Biotechnology Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Granta Biotechnology Limited sell?
Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GRANTA BIOTECHNOLOGY LIMITED is an active private limited company (company number 04880477) incorporated on 28 August 2003, registered in Cambridge. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest small accounts cover the period ending 31 March 2026, showing net assets of −£19k, with 0 employees on average. Net assets fell 1% on the prior period (−£19k). Across the last 3 periods on record the net-asset trend is flat.
Peer position · net assets
By net assets it sits in the bottom quarter of 193 comparable companies in Cambridge (median £6,914, upper quartile £134k).
02
Ownership and control
- Dr Jason Peter Brown
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 28 August 200323 yrs ago
- Next accounts due
- 31 December 2027in 429 days
- Confirmation statement due
- 11 September 2027in 318 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not reported
0
vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | −£19k | — | — | — | — | — | 0 |
| 31 March 2025 | −£19k | — | — | — | — | — | 0 |
| 31 March 2024 | −£19k | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-19,373 at 31 March 2026
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 28 August 2003
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 429 days
- Confirmation statement duein 318 days
- Accounts period endNet liabilities £19k · small accounts
- Accounts period endNet liabilities £19k · small accounts
- Accounts period endNet liabilities £19k · small accounts
- Incorporated
08
Similar companies in Cambridge
- ALTERIX LIMITEDCambridge · inc. Aug 2003
- IGENNUS LIMITEDCambridge · inc. Oct 2003
- DISPLAYLINK (UK) LIMITEDCambridge · inc. Jun 2003
- OWLSTONE MEDICAL LIMITEDCambridge · inc. Nov 2003
- BLUEWOLF COMMUNICATIONS LIMITEDWhittlesford · inc. Nov 2003
- MOLECULAR SYNTHETICS LIMITEDCambridge · inc. Dec 2003
All companies incorporated on 28 August 2003 · in Aug 2003.
09
Reminders for GRANTA BIOTECHNOLOGY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.